In a press release Wednesday, Israel-based specialty medical device company Inspira Technologies (NASDAQ:IINN) disclosed that it is developing the HYLA blood sensor. This non-invasive blood sensor could have a major impact on the medical market. Furthermore, the announcement seems to have catalyzed a 100% move in IINN stock.
For patients, it should be a relief to know that the HYLA blood sensor doesn’t require the taking of actual blood samples. Medical practitioners, meanwhile, should be glad to discover that the sensor can perform real-time and continuous blood monitoring, which could quickly alert physicians of signs of changes in a patient’s condition.
What’s Happening with IINN Stock?
The post Why Is Inspira Technologies (IINN) Stock Up 100%? originally appeared at InvestorPlace.